Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia
Status:
Completed
Trial end date:
2017-09-04
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of CJ-30060 compared with amlodipine/valsartan
combination therapy and valsartan/rosuvastatin combination therapy in hypertensive patients
with hyperlipidemia